Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application

Wenjie Sun,1 Shuying Li,1 Guiliang Tang,1 Yuan Luo,1 Shijing Ma,1 Shaoxing Sun,1 Jiangbo Ren,2 Yan Gong,2 Conghua Xie1,3,4 1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China; 2Department of Biological Repositories, Zhongn...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Sun W, Li S, Tang G, Luo Y, Ma S, Sun S, Ren J, Gong Y, Xie C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	nanomedicine theranostic platform biomedical imaging combination therapy clinical translation Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/e540f169513a487d8f44b83d7d1d645c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:e540f169513a487d8f44b83d7d1d645c
record_format	dspace
spelling	oai:doaj.org-article:e540f169513a487d8f44b83d7d1d645c2021-12-02T11:36:53ZRecent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application1178-2013https://doaj.org/article/e540f169513a487d8f44b83d7d1d645c2020-01-01T00:00:00Zhttps://www.dovepress.com/recent-progress-of-nanoscale-metal-organic-frameworks-in-cancer-theran-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Wenjie Sun,1 Shuying Li,1 Guiliang Tang,1 Yuan Luo,1 Shijing Ma,1 Shaoxing Sun,1 Jiangbo Ren,2 Yan Gong,2 Conghua Xie1,3,4 1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China; 2Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China; 3Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China; 4Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of ChinaCorrespondence: Conghua Xie; Yan GongZhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, Hubei 430071, People’s Republic of ChinaTel +86-27-67812607; +86-27-67871471Fax +86-27-67812892; +86-27-67811461Email chxie_65@whu.edu.cn; yan.gong@whu.edu.cnAbstract: The growing incidence of cancer raises an urgent need to develop effective diagnostic and therapeutic strategies. With the rapid development of nanomedicine, nanoscale metal-organic frameworks (NMOFs) presented promising potential in various biomedical applications in the last 2 decades, especially in cancer theranostics. Due to the unique features of NMOFs, including structural diversities, enormous porosity, multifunctionality and biocompatibility, they have been widely used to deliver imaging contrast agents and therapeutic drugs. Moreover, multiple types of contrast agents, anti-cancer drugs and targeting ligands could be co-delivered through one single NMOF to enable combination therapy. Co-delivering system using NMOFs helped to avoid multidrug resistance, to reduce adverse effects, to achieve imaging-guided precise therapy and to enhance anti-cancer efficacy. This review summarized the recent research advances on the application of NMOFs in biomedical imaging and cancer treatments in the last few years. The current challenges that impeding their translation to clinical practices and the perspectives for their future applications were also highlighted and discussed.Keywords: nanomedicine, theranostic platform, biomedical imaging, combination therapy, clinical translationSun WLi STang GLuo YMa SSun SRen JGong YXie CDove Medical Pressarticlenanomedicinetheranostic platformbiomedical imagingcombination therapyclinical translationMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 10195-10207 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	nanomedicine theranostic platform biomedical imaging combination therapy clinical translation Medicine (General) R5-920
spellingShingle	nanomedicine theranostic platform biomedical imaging combination therapy clinical translation Medicine (General) R5-920 Sun W Li S Tang G Luo Y Ma S Sun S Ren J Gong Y Xie C Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application
description	Wenjie Sun,1 Shuying Li,1 Guiliang Tang,1 Yuan Luo,1 Shijing Ma,1 Shaoxing Sun,1 Jiangbo Ren,2 Yan Gong,2 Conghua Xie1,3,4 1Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China; 2Department of Biological Repositories, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China; 3Hubei Key Laboratory of Tumor Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China; 4Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of ChinaCorrespondence: Conghua Xie; Yan GongZhongnan Hospital of Wuhan University, 169 Donghu Road, Wuhan, Hubei 430071, People’s Republic of ChinaTel +86-27-67812607; +86-27-67871471Fax +86-27-67812892; +86-27-67811461Email chxie_65@whu.edu.cn; yan.gong@whu.edu.cnAbstract: The growing incidence of cancer raises an urgent need to develop effective diagnostic and therapeutic strategies. With the rapid development of nanomedicine, nanoscale metal-organic frameworks (NMOFs) presented promising potential in various biomedical applications in the last 2 decades, especially in cancer theranostics. Due to the unique features of NMOFs, including structural diversities, enormous porosity, multifunctionality and biocompatibility, they have been widely used to deliver imaging contrast agents and therapeutic drugs. Moreover, multiple types of contrast agents, anti-cancer drugs and targeting ligands could be co-delivered through one single NMOF to enable combination therapy. Co-delivering system using NMOFs helped to avoid multidrug resistance, to reduce adverse effects, to achieve imaging-guided precise therapy and to enhance anti-cancer efficacy. This review summarized the recent research advances on the application of NMOFs in biomedical imaging and cancer treatments in the last few years. The current challenges that impeding their translation to clinical practices and the perspectives for their future applications were also highlighted and discussed.Keywords: nanomedicine, theranostic platform, biomedical imaging, combination therapy, clinical translation
format	article
author	Sun W Li S Tang G Luo Y Ma S Sun S Ren J Gong Y Xie C
author_facet	Sun W Li S Tang G Luo Y Ma S Sun S Ren J Gong Y Xie C
author_sort	Sun W
title	Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application
title_short	Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application
title_full	Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application
title_fullStr	Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application
title_full_unstemmed	Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application
title_sort	recent progress of nanoscale metal-organic frameworks in cancer theranostics and the challenges of their clinical application
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/e540f169513a487d8f44b83d7d1d645c
work_keys_str_mv	AT sunw recentprogressofnanoscalemetalorganicframeworksincancertheranosticsandthechallengesoftheirclinicalapplication AT lis recentprogressofnanoscalemetalorganicframeworksincancertheranosticsandthechallengesoftheirclinicalapplication AT tangg recentprogressofnanoscalemetalorganicframeworksincancertheranosticsandthechallengesoftheirclinicalapplication AT luoy recentprogressofnanoscalemetalorganicframeworksincancertheranosticsandthechallengesoftheirclinicalapplication AT mas recentprogressofnanoscalemetalorganicframeworksincancertheranosticsandthechallengesoftheirclinicalapplication AT suns recentprogressofnanoscalemetalorganicframeworksincancertheranosticsandthechallengesoftheirclinicalapplication AT renj recentprogressofnanoscalemetalorganicframeworksincancertheranosticsandthechallengesoftheirclinicalapplication AT gongy recentprogressofnanoscalemetalorganicframeworksincancertheranosticsandthechallengesoftheirclinicalapplication AT xiec recentprogressofnanoscalemetalorganicframeworksincancertheranosticsandthechallengesoftheirclinicalapplication
_version_	1718395795014680576

Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application

Ejemplares similares